期刊文献+

血清CGA、NT-proBNP、Hs-CRP水平与冠心病的相关性研究 被引量:4

Correlation between levels of CGA,NT-proBNP and Hs-CRP in serum and coronary heart disease
下载PDF
导出
摘要 目的探讨血清嗜铬粒蛋白(CGA)、氨基末端脑钠肽前体(NT-proBNP)、高敏C-反应蛋白(Hs-CRP)水平与冠心病的相关性。方法选取2011年11月-2012年11月间于我院接受检查和治疗的冠心病患者64例作为观察组;选取排除了冠心病的64例患者作为对照组。检测两组患者的血清CGA、NT-proBNP、Hs-CRP水平,分析其与冠心病发病的相关性。结果观察组患者血清的CGA、NT-proBNP、Hs-CRP水平及Gensini评分均明显高于对照组(P<0.05)。观察组患者血清CGA水平与Gensini评分呈正相关(r=0.313,P<0.05);观察组患者血清NT-proBNP水平与Gensini评分呈正相关(r=0.269,P<0.05);观察组患者血清Hs-CRP水平与Gensini评分呈正相关(r=0.587,P<0.05)。血清CGA、NT-proBNP、Hs-CRP三者联合检测的诊断阳性例数与单独检测的诊断阳性例数比较有统计学差异(P<0.05)。结论血清CGA、NT-proBNP、Hs-CRP水平与冠心病密切相关,作为冠心病发病的检测指标三者均具有很高的预测价值。 Objective To study the correlation between serum chromogranin A (CGA), N-terminal pro-brain natriuretic peptide (NT-proBNP) and high-sensitivity C-reactive protein (Hs-CRP) levels and coronary heart disease (CHD). Methods Sixty-four patients with CHD were enrolled as observation group and another 64 patients without CHD as control group. The levels CGA, NT- proBNP and Hs-CRP in serum were detected. Their correlation with CHD was analyzed based on the findings. Results The serum CGA, NT-proBNP and Hs-CRP levels and Gensini score of the observation group were significantly higher than that of the control group ( P 〈 0.05 ). The levels serum CGA, NT-proBNP and Hs-CRP of the observation group were positively correlated with Gensi- ni score ( r = 0.313, P 〈 0.05 ; r = 0. 269, P 〈 0.05 ; r = 0. 587, P 〈 0.05). Triple joint diagnosis made a significant difference compared with separate detection ( P 〈 0.05 ). Conclusion Serum CGA, NT-proBNP and Hs-CRP levels are closely related to CHD and had a highly predictive value.
出处 《临床军医杂志》 CAS 2014年第11期1101-1103,1106,共4页 Clinical Journal of Medical Officers
关键词 嗜铬粒蛋白 氨基末端脑钠肽前体 高敏C-反应蛋白 冠心病 chromogranin A N-terminal pro-brain natriuretic peptide high-sensitivity C-reactive protein coronary heart disease
  • 相关文献

参考文献11

二级参考文献72

  • 1赵思勤,李秋,吴涛,刘小蓉,赵宁,聂晓莉,王勉,胡咏梅.心力衰竭患者脑利钠肽浓度与血流动力学的关系及临床意义[J].中华心血管病杂志,2005,33(6):502-504. 被引量:40
  • 2Mehra MR, Maisel A. B - Type Natriuretic Peptide in Heart Failure :Diagnostic, Prognostic, and Therapeutic Use [ J ]. Crit Pathw Cardiol, 2005,4( 1 ) :10 -20.
  • 3Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease[ J]. Am J Cardiol, 1983,51 ( 3 ) : 606.
  • 4James A de Lemos, Darren K McGuire, Mark H Drazner. B-type natriuretic peptide in cardiovascular disease [ J ]. Lancet, 2003,362 : 316 -22.
  • 5Expert Panel on Detection, Evaluation, and Treatment of HighBlood Cholesterol in Adults. Executive summary of the third report of the national cholesterol education program(NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol in Adults( Adult Treatment Panel Ⅲ) [ J ]. JAMA, 2001,285 : 2486 - 97.
  • 6Berry C, Tardif JC, Bourassa MG. Coronary heart disease in patients with diabetes:part I:recent advances in prevention and noninvasive management[J]. J Am Coll Cardiol,2007,49(6) :631 -42.
  • 7Cariou B, Bonnevie L, Mayaudon H, et al. Angiographic characteristics of coronary artery disease in diabetic patients compared with matched non-diabetic subject, diabetes [ J ]. Nutr Metab, 2000,13 : 134 -41.
  • 8Wemer GS, Richartz BM, Heinke S, et al. Impaired acute collateral recruitment as a possible mechanism fofincreased cardiac adverse events in patients with diabetes mellitus [ J ]. Eur Heart J, 2003,24 : 1134 -42.
  • 9Goraya TY, Leibson CL, Palumbo PJ, et al. Coronary atherosclerosis in diabetes mellitus : a population-based autopsy study [ J ]. J Am Coil Cardiol,2002,40 (5) :946 - 53.
  • 10Baba S, Iso H, Mannami T, et al. Cigarette smoking and risk of coronary heart disease incidence among middle-aged Japanese men and women:the JPHC Study Cohort [ J ]. Eur J Cardiovasc Prey Rehabil, 2006,13(2) :207 - 13.

共引文献39

同被引文献36

引证文献4

二级引证文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部